-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JFnD3hX4Hkw0JAYyoXriHD5o/HaQIiT5HDHC4T00uEmpxYU0HFENMFp97epWTJf+ +zEni7k8CGFyAYHKNEMCuQ== 0001144204-08-022687.txt : 20080415 0001144204-08-022687.hdr.sgml : 20080415 20080415182829 ACCESSION NUMBER: 0001144204-08-022687 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080411 FILED AS OF DATE: 20080415 DATE AS OF CHANGE: 20080415 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROGEN CORP CENTRAL INDEX KEY: 0000849043 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222845714 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: 2034888201 MAIL ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAKER FELIX CENTRAL INDEX KEY: 0001087940 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18311 FILM NUMBER: 08758487 BUSINESS ADDRESS: STREET 1: TISCH FAMILY INTERESTS STREET 2: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 212-339-5600 MAIL ADDRESS: STREET 1: BAKER BROTHERS ADVISORS STREET 2: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BAKER JULIAN CENTRAL INDEX KEY: 0001087939 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18311 FILM NUMBER: 08758488 BUSINESS ADDRESS: STREET 1: TISCH FAMILY INTERESTS STREET 2: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 BUSINESS PHONE: 212-339-5600 MAIL ADDRESS: STREET 1: BAKER BROTHERS ADVISORS STREET 2: 667 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Baker Bros. Capital (GP), LLC CENTRAL INDEX KEY: 0001244390 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18311 FILM NUMBER: 08758489 BUSINESS ADDRESS: STREET 1: 667 MADISON AVE 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 BUSINESS PHONE: 212-339-5600 MAIL ADDRESS: STREET 1: 667 MADISON AVE 17TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10065 FORMER NAME: FORMER CONFORMED NAME: BAKER BROS CAPITAL GP LLC DATE OF NAME CHANGE: 20030619 4 1 form415260_041508183110-.xml X0202 4 2008-04-11 0 0000849043 NEUROGEN CORP NRGN 0001244390 Baker Bros. Capital (GP), LLC 667 MADISON AVENUE 17TH FLOOR NEW YORK NY US 10021 1 0 1 0 0001087939 BAKER JULIAN 667 MADISON AVENUE, 17TH FLOOR NEW YORK NY US 10021 1 0 1 0 0001087940 BAKER FELIX 667 MADISON AVENUE, 17TH FLOOR NEW YORK NY US 10021 1 0 1 0 Series A Convertible Preferred Stock 2008-04-11 4 P 0 9904 31.2 A Common Stock 257504 9904 I Through Partnership Common Stock Warrants 2.3 2008-04-11 4 P 0 9904 31.2 A 2009-04-11 2013-04-11 Common Stock 128752 9904 I Through Partnership In addition to Baker Bros. Capital (GP), LLC, this Form 4 is being filed jointly by Felix J. Baker and Julian C. Baker, each of whom has the same business address as Baker Bros. Capital (GP), LLC and may be deemed to have a pecuniary interest in securities owned by it. Felix J. Baker and Julian C. Baker are directors of the Issuer. Because of certain relationships with other security holders of the Issuer, the Reporting Persons are filing solely for informational purposes as if they were members of a group with such security holders. (Continued in footnote 2) However, the Reporting Persons disclaim that they and any other person or persons in fact constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d 5 thereunder or that they are the beneficial owner of securities owned by such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein. The initial exchange price of the Convertible Preferred Stock shall be $1.20 per share, resulting in an initial exchange rate of 26 shares of common stock for each convertible preferred share. Represents 4,644 Series A Preferred shares purchased by Baker Bros. Investments II, L.P. and 5,260 Series A Preferred shares purchased by Baker Bros. Investments, L.P. The earlier of (i) stockholder approval of the exchange of Series A Convertible Preferred Stock into Common Stock of the Issuer or (ii) the one year anniversary of the issuance date on April 11, 2008. The Series A Convertible Preferred Stock has no expiration date. One share of Series A Convertible Preferred Stock and one Warrant were purchased for an aggregate purchase price of $31.20 per unit. Represents 4,644 Series A Preferred shares owned directly by Baker Bros. Investments II, L.P. and 5,260 shares owned directly by Baker Bros. Investments, L.P., limited partnerships of which the sole general partner is Baker Bros. Capital, L.P., a limited partnership of which the sole general partner is Baker Bros. Capital (GP), LLC. Felix J. Baker and Julian C. Baker are controlling members of Baker Bros. Capital (GP), LLC. Represents 4,644 Warrants purchased by Baker Bros. Investments II, L.P. and 5,260 Warrants purchased by Baker Bros. Investments, L.P. Represents 4,644 warrants owned directly by Baker Bros. Investments II, L.P. and 5,260 shares owned directly by Baker Bros. Investments, L.P., limited partnerships of which the sole general partner is Baker Bros. Capital, L.P., a limited partnership of which the sole general partner is Baker Bros. Capital (GP), LLC. Felix J. Baker and Julian C. Baker are controlling members of Baker Bros. Capital (GP), LLC. /s/ Julian C. Baker, as Managing Member of Baker Bros. Capital (GP), LLC 2008-04-15 /s/ Julian C. Baker 2008-04-15 /s/ Felix J. Baker 2008-04-15 -----END PRIVACY-ENHANCED MESSAGE-----